RNAi-mediated β-catenin Inhibition Impairs Tumor Growth in Multiple Immunocompetent CTNNB1-mutated and non-CTNNB1-mutated HCC Mouse Models with Durable Response in Early-stage Disease Setting. Here, CTNNB1 is linked to neoplasm.